Advertisement Press Releases Archive - Page 128 of 233 - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Pressreleases

Search

  • 19 Jul 2013
    PHT Corporation MyStudyHome™ Community Keeps Clinical Research Sites Engaged and Compliant

    PHT Corporation MyStudyHome™ Community Keeps Clinical Research Sites Engaged and Compliant

    By admin

    PHT Corporation launched the MyStudyHome™ online community that connects sponsors with sites to share up-to-date training and documentation, calendars, and study specific updates. MyStudyHome gives pharmaceutical sponsors and CROs a competitive edge in retaining high performing clinical trial investigation sites and improving site engagement and compliance. PHT Corporation is the leading provider of innovative technology systems used to collect patient-driven eData for clinical research.

  • 19 Jul 2013
    PHT Corporation Achieves Record Revenues in 2012

    PHT Corporation Achieves Record Revenues in 2012

    By admin

    PHT Corporation accomplished its 4th consecutive year of profitable growth in 2012 as sponsors, CROs and sites worldwide adopted its ePRO and eCOA Systems to collect patient-driven eData for clinical research programs.

  • 19 Jul 2013
    Aptalis Pharmaceutical Technologies Co-Sponsors 2013 Controlled Release Society’s Young Investigator Award at 40th Annual Meeting and Exposition

    Aptalis Pharmaceutical Technologies Co-Sponsors 2013 Controlled Release Society’s Young Investigator Award at 40th Annual Meeting and Exposition

    By admin

    Bridgewater, New Jersey, July 18, 2013 -- Aptalis Pharmaceutical Technologies, a business unit of Aptalis Pharma that focuses on developing patient-optimized oral products utilizing its proprietary pharmaceutical technologies and development expertise, today announces its cosponsorship of Controlled Release Society's Young Investigator Award. The award will be presented during the 40th Annual Meeting & Exposition of the Controlled Release Society July 21 - 24, 2013 in Honolulu, Hawaii.

  • 15 Jul 2013
  • 11 Jul 2013
    European F-Gas Regulation and Medical Applications

    European F-Gas Regulation and Medical Applications

    By admin

    Whilst having many positive attributes, the proposed revisions to the regulation of fluorinated greenhouse gases (F-Gases) currently going through the co-decision procedure in Europe will have a significant impact on the application of F-Gases for medical uses.

  • 03 Jul 2013
  • 02 Jul 2013
  • 02 Jul 2013
    Hybrigenics acquires Dualsystems Biotech’s yeast two-hybrid (Y2H) activities

    Hybrigenics acquires Dualsystems Biotech’s yeast two-hybrid (Y2H) activities

    By admin

    Hybrigenics (ALHYG), a bio-pharmaceutical company listed on Alternext (NYSE-Euronext) in Paris, announces the acquisition by Hybrigenics Services, its subsidiary specialized in protein interactions, of the yeast two-hybrid (Y2H) activities of Dualsystems Biotech, a privately owned Swiss company based in Schlieren near Zurich. Financial terms are not disclosed and will not involve the issuance of any Hybrigenics shares.

  • 30 Jun 2013
  • 27 Jun 2013
    Arena International Presents Pharmaceutical Packaging & Labelling 2013

    Arena International Presents Pharmaceutical Packaging & Labelling 2013

    By admin

    September 2013 sees the welcome return of the 12th Annual Pharmaceutical Packaging & Labelling conference; Providing a platform for industry leaders, innovators and decision makers to meet, discuss and showcase vital strategies important to maintain grow and expand an industry facing tougher regulations relating to the packaging & labelling of pharmaceutical products.

«‹126127128129130›»